NextCure, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 2.67 M | $3.66 B | 0.00% | 9.55% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 2.50 M | $3.43 M | 0.00% | 8.94% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 2.30 M | $3.15 M | 36.41% | 8.23% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 1.14 M | $1.56 M | 0.00% | 4.08% |
| VANGUARD GROUP INC | 11/13/2024 | 987,324 | $1.35 M | 0.00% | 3.53% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 729,836 | $999,876 | 100.00% | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 652,386 | $893,769 | 8.19% | 2.33% |
| CABLE CAR CAPITAL LLC | 11/14/2024 | 615,878 | $843,753 | 0.00% | 2.20% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/13/2024 | 556,105 | $761,864 | 0.00% | 1.99% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 488,440 | $667,000 | 0.00% | 1.75% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 406,000 | $556,220 | -12.15% | 1.45% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 342,592 | $469,351 | 5.95% | 1.22% |
| BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 276,465 | $378,757 | 0.00% | 0.99% |
| CARDIFF PARK ADVISORS, LLC | 11/14/2024 | 262,000 | $358,940 | 0.00% | 0.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 223,741 | $306,596 | 14.19% | 0.80% |
| MACQUARIE GROUP LTD | 11/14/2024 | 150,000 | $206,000 | 0.00% | 0.54% |
| SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 130,000 | $178,100 | 0.00% | 0.46% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 120,013 | $164,418 | 34.82% | 0.43% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 107,672 | $147,511 | -47.17% | 0.38% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 100,000 | $137,000 | 177.78% | 0.36% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 85,853 | $117,618 | -0.82% | 0.31% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 85,308 | $116,872 | -53.76% | 0.30% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 72,119 | $98,803 | -84.27% | 0.26% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 70,600 | $96,722 | 0.00% | 0.25% |
| BARCLAYS PLC | 11/19/2024 | 67,518 | $92,000 | 0.00% | 0.24% |
| STATE STREET CORP | 11/14/2024 | 65,392 | $89,587 | 0.00% | 0.23% |
| MARQUETTE ASSET MANAGEMENT, LLC | 10/08/2024 | 58,259 | $79,815 | 0.00% | 0.21% |
| CITADEL ADVISORS LLC | 11/14/2024 | 55,954 | $76,657 | -80.64% | 0.20% |
| IEQ CAPITAL, LLC | 11/14/2024 | 37,342 | $51,159 | 0.00% | 0.13% |
| LPL FINANCIAL LLC | 11/08/2024 | 27,000 | $36,990 | -10.00% | 0.10% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 23,800 | $32,606 | -13.77% | 0.09% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 21,247 | $29,108 | 0.00% | 0.08% |
| ENGINEERS GATE MANAGER LP | 11/14/2024 | 10,774 | $14,760 | 100.00% | 0.04% |
| HARBOURVEST PARTNERS LLC | 11/14/2024 | 10,044 | $13,760 | 0.00% | 0.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 10,000 | $13,700 | 0.00% | 0.04% |
| UBS GROUP AG | 11/14/2024 | 5,466 | $7,489 | -44.94% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 5,390 | $7,384 | 0.39% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,191 | $1,631 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 807 | $1,106 | 0.12% | 0.00% |
| MORGAN STANLEY | 11/14/2024 | 1 | $1 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/15/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
NextCure, Inc.institutional Ownership - FAQ's
During the previous two years, 54 institutional investors and hedge funds held shares of NextCure, Inc.. The most heavily invested institutionals were:
Sofinnova Investments, Inc.: 2.67 M
Logos Global Management LP: 2.5 M
Affinity Asset Advisors, LLC: 2.3 M
ORBIMED ADVISORS LLC: 1.14 M
VANGUARD GROUP INC: 987,324
BlackRock Funding, Inc. /DE: 729,836
56.71% of NextCure, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.45 M shares in the last 24 months. This purchase volume represents approximately $14.48 M in transactions.